The loss of Tregs caused by CD137 mAb could reverse the immunosuppressive environment and simultaneously affect CD8+ T cells in the tumor while also allowing new CD8+ T cells to infiltrate the TME (27). The gene discussed is TNFRSF9; the disease is neoplasm.